Vascularized Bone Marrow Cellular Depletion or Discontinuity Abrogates Protection of Vascularized Composite Allografts in Nonhuman Primates
Background. Vascularized composite allografts (VCA) have demonstrated good clinical outcomes dependent on chronic immunosuppression. Previous work by our group and others supports that cotransplanted vascularized bone marrow (VBM) as a component of VCA offers immunologic protection to prolong graft...
Main Authors: | Nicole Shockcor, MD, Evan B. Buckingham, MD, Wessam Hassanein, MBBCH, Urmil Dhru, MSc, Ali Khalifeh, MD, Mehmet Uluer, MD, Jhade Woodall, MD, Philip Brazio, MD, Cynthia Drachenberg, MD, Arthur J. Nam, MD, Rolf N. Barth, MD |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2021-02-01
|
Series: | Transplantation Direct |
Online Access: | http://journals.lww.com/transplantationdirect/fulltext/10.1097/TXD.0000000000001107 |
Similar Items
-
Partial Loss of Nasal Tissue in a Facial Vascularized Composite Allograft Patient
by: Martin Kauke, MD, et al.
Published: (2020-08-01) -
Vascularized Thymosternal Composite Tissue Allo- and Xenotransplantation in Nonhuman Primates: Initial Experience
by: Selin Sendil, MD, et al.
Published: (2017-12-01) -
Endovascular repair of a cadaveric vascular allograft nonanastomotic pseudoaneurysm
by: Marvin Chau, BS, et al.
Published: (2020-12-01) -
QS7: Effect Of Static Cold Storage On Vascularized Composite Allografts
by: Marion Goutard, M.D, et al.
Published: (2021-07-01) -
QS9: Decellularization Of Vascularized Composite Allografts In The Rat
by: ELISE LUPON, M.D, et al.
Published: (2021-07-01)